Troglitazone-induced inhibition of l-type calcium currents is augmented in streptozotocin-induced diabetic rat cardiac ventricular myocytes
- Author:
M.Arikawa
;
N.Takahashi
;
T.Ooie
;
S.Shigematsu
;
M.Hara
;
T.Sakata
;
T.Saikawa
- Publication Type:Journal Article
- From:
Chinese Journal of Pathophysiology
2001;17(8):767-
- CountryChina
- Language:Chinese
-
Abstract:
Troglitazone, a member of the insulin-sensitizing thiazolidinediones, was shown to suppress voltage-dependent L-type calcium currents (ICa, L) in vascular smooth muscle cells. The present study was aimed to investigate whether troglitazone may inhibit ICa, L in rat cardiac ventricular myocytes and whether the extent of troglitazone-induced inhibition of the current may be different between normal and streptozotocin (STZ)-induced diabetic rats. Whole-cell patch-clamp techniques were applied in single rat ventricular myocytes. Troglitazone reduced the amplitude of ICa, L in a concentration-dependent manner in both normal and diabetic myocytes. However, the percent inhibition of ICa, L by troglitazone in concentration of 10-5mol/L measured at a holding potential of -50 mV was significantly greater in myocytes isolated from STZ-induced diabetic rats than in control rats (87%±8% vs 47%±5%, P＜0.005), without difference in voltage-dependency of the inhibition. These findings demonstrate that troglitazone-induced inhibition of ICa, L is augmented in STZ-induced diabetic cardiac ventricular myocytes, thus possibly playing a role in preventing intracellular calcium overload.
